All patients being screened for this study will be required to give informed consent. In order to recruit the proposed study numbers for the active intervention we estimate that we will have to screen approximately 100 patients. A large number of patients may be excluded from the active intervention study as baseline clinical and laboratory investigations, completed as part of their standard disease assessment, will suggest they have active disease. However data collected on these patients will still provide valuable information about fatigue in patients with IBD, such as any association between fatigue score and severity of active disease, or other parameters such as somatisation score (as assessed by PHQ15 form), quality of life (SIBDQ & SF36), overlapping IBD symptoms (Rome III criteria), or anxiety and depression (HAD score).